(PharmaNewsWire.Com, September 28, 2017 ) The Europe mycoplasma testing market was worth USD 111.6 Million in 2016 and is estimated to be growing at a CAGR of 12.6%, to reach USD 202.07 Million by 2021. Mycoplasma is a prokaryotic organism which is often responsible for the contamination of cell cultures. This organism has the ability to alter certain features of cell physiology resulting in the invalidity of the experiments conducted.
Because of its small size, they easily pass through filters that usually prevent contamination from fungus and bacteria and easily spread to other cell cultures in the laboratory. Hence, it is necessary that cell cultures entering a laboratory are to be tested to detect the presence of mycoplasma and the laboratory itself is also to be tested. There are many mycoplasma testing methods available in the market.
Rising expenditure for research and development activities in pharmaceutical and biotechnology companies, increased R&D activities in life sciences and increasing incidence of mycoplasma infections in cell cultures are the major factors driving the growth of mycoplasma testing market in Europe region. High degree of market consolidation and increase in expenditure for mycoplasma testing are the major restraining factors for the market.
Market Segmentation
Product Kits & Reagent o PCR Assays o Nucleic Acid Detection Kits o Elimination Kits & Reagents o Stains o Standards & Controls o Other Kits & Reagents Instruments Services Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product
Technique PCR ELSA Direct Assays Indirect Assays Microbial culture techniques Enzymatic Methods DNA Staining Y-o-Y Growth Analysis, By Technique Market Attractiveness Analysis, By Technique Market Share Analysis, By Technique
Application Cell Line Testing Virus Testing End-Of-Production Cell Testing Other Applications Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application
End User Pharmaceutical Companies Contract Research Organizations Academic Research Institutes Cell Banks Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User
Based on geography, the Europe market for mycoplasma testing is segmented into UK, Germany, France, Spain and Italy regions. Germany leads the mycoplasma testing market owing to the increase in number of pharmaceutical industries in this region.
The major companies in the mycoplasma testing market are Thermo Fisher Scientific Inc., American Type Culture Collection, Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Biological Industries Israel Beit Haemek Ltd., Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., InvivoGen, PromoCell GmbH, and WuXi AppTec.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
